Abstract
Heart disease is the major health issue facing women in the United States today. Yet, less than 50% of women are aware cardiovascular disease is a health problem. Atherosclerosis begins in childhood and lipid streaks have been identified in girls ages 15–19 in the abdominal aorta and the right coronary artery. Risk factors for cardiovascular disease in women include smoking, diabetes, hypertension, lipid disorders, and menopause. Observational studies have reported a 30–50% reduction in cardiovascular events when estrogen was administered to younger women for menopausal symptoms, yet randomized trials in older patients have failed to show benefit with hormonal replacement therapy. Recent studies have reported preservation of lipid and vascular vasodilatation with low-dose conjugated equine estrogens (CEE) in women and an absence of inflammatory and clotting changes that were observed in high-dose CEE. Recommendations for reducing cardiovascular risk in postmenopausal women include smoking cessation, regular exercise, and weight control. Should hormone therapy be continued beyond management of menopausal symptoms and treatment for osteoporosis, a statin drug should be added to eliminate future cardiovascular complications. Future research will examine low-dose hormonal therapy, earlier administration after menopause, newer agents, and routes of estrogen administration.
Similar content being viewed by others
References
National Center for Health Statistics (1999). pp. 164–167.
Mosca, L., Ferris, A., Fabunmi, R., and Robertson, R. M. (2004). Circulation 109, 573–579.
Wenger, N. K. (2004) Circulation 109, 558–560.
Virchow, R. (1858).
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. (1999). JAMA 298, 727–735.
Napoli, C., D’Aromento, F. P., Mancini, F. T., et al. (1997). J. Clin. Invest. 100, 2680–26990.
Rackley, C. E. and Rackley, E. B. (1999). J. Noninvas. Cardiol. 3, 95–99.
Little, W. C., Constantinescu, M., Applegate, R. J., et al. (1988). Circulation 78, 1157–1166.
Rackley, C. E. (2002). Cardiology in Review 10, 119–125.
Hsia, J., Aragaki, A., Bloch, M., LaCroix, A. Z., Wallace, R., for the WHI Investigators. (2004). Am. J. Cardiol. 93, 673–678.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III). (2001). JAMA 285, 2486–2497.
Heilbron, L. K., NoAkes, M., and Clifton, P. M. (2001). Arterioscler. Thromb. Vasc. Biol. 21, 968–970.
Kip, K. E., Marroquin, O. C., Kelley, D. E., et al. (2004). Circulation 109, 706–713.
Clarkson, T. B., Kaplan, J. R., Wagner, J. D., et al. (2002). Cardiovascular health and disease in women. 2nd ed. Harcourt Health Sciences/W. B. Saunders, Philadelphia, PA, Chapter 13, p. 231.
Post, W., Goldschmidt-Clearmont, P. J., Wilhide, C. C. et al. (1999). Cardiovas. Res. 43, 985–991.
Sullivan, J. M., Vander Zwaag, R., Lemp, G. F., et al. (1988). Ann. Inter. Med. 108, 358–363.
Hong, M. K., Romm, P. A., Reagan, K., Green, C. E., and Rackley, C. E. (1992). Am. J. Cardiol. 69, 176–178.
Husak, L., Vaccarino, V., Veledar, E., Murrah, N., and Wenger, N. K. (2004). Am. J. Cardiol. 93, 563–568.
Williams, J. K., Anthony, M. S., Honore, E. K. et al. (1995) Arterioscler. Thromb. Vasc. Biol. 15, 827–836.
Lindsay, R., Hart, D. M., Aitken, J. M., et al. (1976). Lancet 1, 1038–1041.
Hulley, F., Grady, D., Bush, T., et al. (1998). JAMA 280, 605–613.
Writing Group for the Women’s Health Initiative Investigators. (2002). JAMA 288, 321–333.
Koh, K. K., Ahn, J. Y., Seung, H. H., Shin, M. S., Ahn, T. H., and Shin, E. K. (2004). J. Am. Coll. Cardiol. 43, 5–3A.
Wakatshuki, A., Ikenoue, N., Shinohara, K., Watanave, K., and Furkay, T. (2004). Arterioscler. Thromb. Vasc. Biol. 24, 571–576.
Stampfer, M. J., Willett, W. C., Colditz, G. A., Rosner, B., Speizer, F. E., and Hennekens, C. H. (1985). N. Engl. J. Med. 313, 1044–1049.
Falkeborn, M., Persson, I., Adami, H. O., et al. (1992). Br. J. Obstet. Gynecol. 99, 821–827.
Goldstein, F., Stampfer, M. J., Manson, J. E., et al. (1996). N. Engl. J. Med. 335, 453–461.
Grodstein, F., Manson, J. E., Colditz, G. A., et al. (2000). Ann. Intern. Med. 133, 933–942.
Hsia, J., Manson, J. E., Johnson, K. C., et al., for the Women’s Health Initiative Investigators. (2003). Circulation 108, IV-787.
Hambrecht, R., Walther, C., Molrus-Winhler, S. Gielen, S., et al. (2004). Circulation 109, 1371–1378.
Abisaid, A., Albertal, M., Costa, M. A., et al. (2004). J. Am. Coll. Cardiol. 43, 1118–1121.
Dorons, J. R., Clearfield, M., Weis, S. et al. (1998). JAMA 279, 1615–1622.
Herrington, D. M., Viltinghoff, E., Lin, F., et al. (2002). Circulation 105, 2962–2967.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rackley, C.E. Hormones and coronary atherosclerosis in women. Endocr 24, 245–250 (2004). https://doi.org/10.1385/ENDO:24:3:245
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:24:3:245